a 2019

Inflammatory bowel disease incidence in South Moravian Region (Czech Republic); 2002-2016

JABANDŽIEV, Petr, Tereza PINKASOVÁ, Jan PAPEŽ, Martin JOUZA, Kateřina BAJEROVÁ et. al.

Basic information

Original name

Inflammatory bowel disease incidence in South Moravian Region (Czech Republic); 2002-2016

Authors

JABANDŽIEV, Petr (203 Czech Republic, guarantor, belonging to the institution), Tereza PINKASOVÁ (203 Czech Republic, belonging to the institution), Jan PAPEŽ (203 Czech Republic, belonging to the institution), Martin JOUZA (203 Czech Republic, belonging to the institution), Kateřina BAJEROVÁ (203 Czech Republic, belonging to the institution), Bára KARLÍNOVÁ (203 Czech Republic, belonging to the institution), Júlia KOVÁČOVÁ (703 Slovakia), Ondřej SLABÝ (203 Czech Republic, belonging to the institution) and Milan BAJER (203 Czech Republic, belonging to the institution)

Edition

Crohn's and Colitis Congress, 2019

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30209 Paediatrics

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 17.373

RIV identification code

RIV/00216224:14110/19:00111079

Organization unit

Faculty of Medicine

ISSN

DOI

UT WoS

000458180600101

Keywords (in Czech)

zánětlivá střevní onemocnění; děti; jižní Morava

Keywords in English

inflammatory bowel disease; children; South Moravian Region

Tags

Tags

International impact, Reviewed
Změněno: 16/4/2020 08:21, Mgr. Tereza Miškechová

Abstract

V originále

Inflammatory bowel disease is considered a global disease in the 21st century. Studies worldwide have shown an increase in incidence in paediatric population. The aim of the study was to detect the rising incidence of IBD in paediatric population (approximately 240 000) over a 15-year period in the South Moravian Region of the Czech Republic. Another objective was to characterize differences by sex, age and to determine the future projection of incidence of IBD in the region and, by extension, the whole Czech Republic. Methods In the Czech Republic, the treatment of paediatric IBD is centralized into hospitals that provide tertiary care. University Hospital of Brno is one of the gastroenterology centres that provides a complex treatment of IBD patients. We evaluated 321 consecutive paediatric IBD patients < 19 years of age in the South Moravian region (one of the 14 regional units in the Czech Republic). They all had been diagnosed according to the relevant guidelines. Results We evaluated 321 patiens with IBD: 167 of them had Crohn’s disease (52.0%), 114 had ulcerative colitis (35.5%) and 40 were IBD-unclassified (12.5%). Among all the cases of IBD, 53.8% were males. The average age of a diagnosed person was 13.37 years (95%CI: 12.97-13.76) and the patients went an average of 7.59 months (95%CI: 6.15-9.03) between the first symptoms and the diagnosis. The overall incidence of IBD significantly increased from 2.84 per 100 000 person-years in 2002 to 12.54 per 100 000 person-years in 2016 (P = 0.012). Conclusions Our results show that the overal incidence of paediatric IBD is increasing. These data highlight the need for a further research to identify the possible risk factors of IBD development This work was supported by the Ministry of Health of the Czech Republic, grant nr. 16-31314A, 16-31765A and RVO (FnBr, 65269705).